These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8521752)

  • 1. The mechanism of microsomal azoreduction: predictions based on electronic aspects of structure-activity relationships.
    Zbaida S
    Drug Metab Rev; 1995; 27(3):497-516. PubMed ID: 8521752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic microsomal azoreductase activity. Reactivity of azo dye substrates is determined by their electron densities and redox potentials.
    Zbaida S; Brewer CF; Levine WG
    Drug Metab Dispos; 1994; 22(3):412-8. PubMed ID: 8070318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrates for microsomal azoreductase. Hammett substituent effects, NMR studies, and response to inhibitors.
    Zbaida S; Brewer CF; Levine WG
    Drug Metab Dispos; 1992; 20(6):902-8. PubMed ID: 1362944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of two classes of azo dye reductase activity associated with rat liver microsomal cytochrome P450.
    Zbaida S; Levine WG
    Biochem Pharmacol; 1990 Dec; 40(11):2415-23. PubMed ID: 2125221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel application of cyclic voltammetry for direct investigation of metabolic intermediates in microsomal azo reduction.
    Zbaida S; Levine WG
    Chem Res Toxicol; 1991; 4(1):82-8. PubMed ID: 1912304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple mechanisms in hepatic microsomal azoreduction.
    Levine WG; Stoddart A; Zbaida S
    Xenobiotica; 1992; 22(9-10):1111-20. PubMed ID: 1441602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of electronic factors in binding and reduction of azo dyes by hepatic microsomes.
    Zbaida S; Levine WG
    J Pharmacol Exp Ther; 1992 Feb; 260(2):554-61. PubMed ID: 1738106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CASE-SAR study of mammalian hepatic azoreduction.
    Nesnow S; Bergman H; Bryant BJ; Helton S; Richard A
    J Toxicol Environ Health; 1988; 24(4):499-513. PubMed ID: 3411634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Dimethylaminoazobenzenes: carcinogenicities and reductive cleavage by microsomal azo reductase.
    Lambooy JP; Koffman BM
    Chem Biol Interact; 1985; 53(1-2):107-20. PubMed ID: 3922634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of reduction of azo dye carcinogens by rat liver microsomal cytochrome P-450.
    Zbaida S; Stoddart AM; Levine WG
    Chem Biol Interact; 1989; 69(1):61-71. PubMed ID: 2914330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system.
    Tan Y; Patten CJ; Smith T; Yang CS
    Arch Biochem Biophys; 1997 Jun; 342(1):82-91. PubMed ID: 9185616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electron transfer between liver microsomal cytochrome b5 and cytochrome P-450 in the azo reductase reaction.
    Fujita S; Peisach J
    Biochem Biophys Res Commun; 1977 Sep; 78(1):328-35. PubMed ID: 907682
    [No Abstract]   [Full Text] [Related]  

  • 13. Azoreductase activity by purified rabbit liver aldehyde oxidase.
    Stoddart AM; Levine WG
    Biochem Pharmacol; 1992 May; 43(10):2227-35. PubMed ID: 1599508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituent effect on the reductive N-dearylation of 3-(indol-1-yl)-1,2-benzisoxazoles by rat liver microsomes.
    Tschirret-Guth RA; Wood HB
    Drug Metab Dispos; 2003 Aug; 31(8):999-1004. PubMed ID: 12867488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of azoreduction of dimethylaminoazobenzene by rat liver NADPH-cytochrome P-450 reductase and partially purified cytochrome P-450. Oxygen and carbon monoxide sensitivity and stimulation by FAD and FMN.
    Levine WG; Raza H
    Drug Metab Dispos; 1988; 16(3):441-8. PubMed ID: 2900738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A continuous spectrophotometric determination of hepatic microsomal azo reductase activity and its dependence on cytochrome P-450.
    Mallett AK; King LJ; Walker R
    Biochem J; 1982 Mar; 201(3):589-95. PubMed ID: 7092814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilisation, purification and reconstitution of hepatic microsomal azoreductase activity.
    Mallett AK; King LJ; Walker R
    Biochem Pharmacol; 1985 Feb; 34(3):337-42. PubMed ID: 3918538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat liver microsomal azoreductase activity on four azo dyes derived from benzidine, 3,3'-dimethylbenzidine or 3,3'-dimethoxybenzidine.
    Martin CN; Kennelly JC
    Carcinogenesis; 1981; 2(4):307-12. PubMed ID: 7023728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450.
    Goeptar AR; te Koppele JM; van Maanen JM; Zoetemelk CE; Vermeulen NP
    Biochem Pharmacol; 1992 Jan; 43(2):343-52. PubMed ID: 1310854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of varying halogen substituent patterns on the cytochrome P450 catalysed dehalogenation of 4-halogenated anilines to 4-aminophenol metabolites.
    Cnubben NH; Vervoort J; Boersma MG; Rietjens IM
    Biochem Pharmacol; 1995 May; 49(9):1235-48. PubMed ID: 7763304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.